Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Randall Stanicky
Pharma
Viatris, or just Mylan with a new name? Analysts say latter
After Viatris laid out its financial targets for the first time as a combined company, analysts questioned its revenue and cash generation plans.
Angus Liu
Mar 12, 2021 12:09pm
Pfizer's Ibrance fails early breast cancer trial
May 30, 2020 5:41pm
Allergan preparing to split after years of turmoil: analyst
Jun 19, 2019 10:50am
IRS knocks Perrigo for $873M in unpaid royalties
Apr 30, 2019 12:38pm
When is a ph3 flop a good thing? Just ask Allergan's investors
Mar 7, 2019 11:53am
Could Mylan swing a sale to private equity buyer?
Sep 21, 2018 11:27am